Targeting Pain with Novel Therapeutics 2011

TARGETING ION CHANNELS

Sodium Channels as Therapeutic Targets in Pain: Many Isoforms, Many Actions, Many Opportunities
Stephen G. Waxman, M.D., Ph.D., Bridget Marie Flaherty Professor of Neurology, Neurobiology and Pharmacology, Yale University School of Medicine
Design and Pre-Clinical Development of Novel T-Type and N-Type Calcium Channel Blockers for Pain Intervention
Terrance P. Snutch, Ph.D., FCAHS, FRSC, Vice President & CSO, Zalicus, Inc.

THE ENDOCANNABINOID SYSTEM

Endocannabinoid-Based Therapies for Pain
Daniele Piomelli, Ph.D., Italian Institute of Technology, Genoa, Italy; University of California, Irvine
Talk Title to be Announced
Tim Young, Ph.D., Associate Research Fellow, Pfizer
Peripheral CB1/CB2 Agonist for the Treatment of Pain and Inflammation
Robert Spencer, Ph.D., Senior Director, Pre-Clinical Development, Cara Therapeutics

BIOLOGICS FOR PAIN

The Promise of Biologic Drugs for the Treatment of Pain
Iain Chessell, Ph.D., Head, Neuroscience Centre of Excellence, MedImmune

BIOMARKERS

Translational Models and Biomarkers for Pain Therapeutic Development
Mark R. Bowlby, Ph.D., Neurophysiology & Pain Lead, Merck Research Labs
microRNA as Biomarkers in Pain
Seena K. Ajit, Ph.D., Assistant Professor, Pharmacology and Physiology, Drexel University College of Medicine